Prenetics Global (PRE) Current Deferred Revenue (2021 - 2026)

Prenetics Global (PRE) has reported Current Deferred Revenue for 6 consecutive years, with $2.9 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Current Deferred Revenue fell 52.21% year-over-year to $2.9 million; the TTM figure through Mar 2026 stood at $2.9 million (down 52.21% YoY), while the FY2025 annual figure was $3.1 million, down 52.46% from the prior year.
• Current Deferred Revenue eased to $2.9 million in Q1 2026 per PRE's latest filing, from $3.1 million in the prior quarter.
• Across five years, Current Deferred Revenue topped out at $11.5 million in Q1 2022 and bottomed at $2.9 million in Q1 2026.
• Historically, Current Deferred Revenue has averaged $5.9 million across 5 years, with a median of $5.7 million in 2022.
• Annual changes were most pronounced in 2023 — Current Deferred Revenue plunged 62.06% — and 2024, when it jumped 47.96%.
• Prenetics Global's Current Deferred Revenue stood at $5.7 million in 2022, then grew by 7.7% to $6.1 million in 2023, then rose by 6.22% to $6.5 million in 2024, then sank by 52.46% to $3.1 million in 2025, then decreased by 4.47% to $2.9 million in 2026.
• Business Quant data shows PRE's Current Deferred Revenue at $2.9 million in Q1 2026, $3.1 million in Q4 2025, and $7.2 million in Q3 2025.